Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Hedderich, Dennis M., Keicher, Matthias, Wiestler, Benedikt ORCID: 0000-0002-2963-7772, Gruber, Martin J., Burwinkel, Hendrik, Hinterwimmer, Florian ORCID: 0000-0002-0273-0643, Czempiel, Tobias, Spiro, Judith E., Pinto dos Santos, Daniel ORCID: 0000-0003-4785-6394, Heim, Dominik ORCID: 0000-0001-8463-1544, Zimmer, Claus, Rueckert, Daniel, Kirschke, Jan S. and Navab, Nassir (2021). AI for Doctors-A Course to Educate Medical Professionals in Artificial Intelligence for Medical Imaging. Healthcare, 9 (10). BASEL: MDPI. ISSN 2227-9032

Kroeger, Nicolaus, Brand, Ronald, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Weber, Thomas, Robin, Marie, Stelljes, Matthias, Afanasiev, Boris V., Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Gramatzki, Martin, Bethge, Wolfgang A., Poire, Xavier, Kobbe, Guido, van Os, Marleen, Iacobelli, Simona and de Witte, Theo (2014). Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kroeger, Nicolaus, Iacobelli, Simona, Franke, Georg-Nikolaus, Platzbecker, Uwe, Uddin, Ruzena, Huebel, Kai, Scheid, Christof, Weber, Thomas, Robin, Marie ORCID: 0000-0003-1388-9876, Stelljes, Matthias, Afanasyev, Boris, Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco ORCID: 0000-0002-2991-3474, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa ORCID: 0000-0002-9731-8335, Guenther, Andreas, Bethge, Wolfgang, Poire, Xavier, Kobbe, Guido, van Os, Marleen, Brand, Ronald and de Witte, Theo (2017). Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial). J. Clin. Oncol., 35 (19). S. 2157 - 2167. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kroeger, Nicolaus, Iacobelli, Simona, Koster, Linda, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Scheid, Christoph, Weber, Thomas, Stelljes, Matthias, Afanasiev, Boris, Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Guenther, Andreas, Bethge, Wolfgang, Poire, Xavier, Kobbe, Guido, van Os, Marleen, Yakoub-Agha, Ibrahim and Robin, Marie (2018). Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Michel, Christian, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Neubauer, Andreas, Lauseker, Michael, Krause, Stefan W., Kolb, Hans-Jochem, Hossfeld, Dieter Kurt, Nerl, Christoph, Baerlocher, Gabriela M., Heim, Dominik, Bruemmendorf, Tim H., Fabarius, Alice, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Haenel, Mathias, Ho, Anthony, Dengler, Jolanta, Falge, Christiane, Moehle, Robert, Kremers, Stephan, Kneba, Michael, Stegelmann, Frank, Koehne, Claus-Henning, Lindemann, Hans-Walter, Waller, Cornelius F., Spiekermann, Karsten, Berdel, Wolfgang E., Mueller, Lothar, Edinger, Matthias, Mayer, Jiri, Beelen, Dietrich W., Bentz, Martin, Link, Hartmut, Hertenstein, Bernd, Fuchs, Roland, Wernli, Martin, Schlegel, Frank, Schlag, Rudolf, de Wit, Maike, Truemper, Lorenz, Hebart, Holger, Hahn, Markus, Thomalla, Joerg, Scheid, Christof, Schafhausen, Philippe, Verbeek, Walter, Eckart, Michael J., Gassmann, Winfried, Schenk, Michael, Brossart, Peter, Wuendisch, Thomas, Geer, Thomas, Bildat, Stephan, Schaefer, Erhardt, Hasford, Joerg, Hehlmann, Ruediger and Pfirrmann, Markus (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica, 104 (5). S. 955 - 963. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

This list was generated on Thu Mar 28 21:14:34 2024 CET.